简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Petco Health And Wellness第四季度净销售额同比下降个位数; 25财年净销售额下降2.5%至2.8%; 25财年将关闭约20家门店

2025-11-26 05:59

Full Year 2025 Outlook

The company tightened its full year net sales outlook and upwardly revised its full year 2025 earnings guidance increasing the midpoint of its expected adjusted EBITDA range by $6 million. In addition, the company provided its outlook for the fourth quarter of 2025.



 
FY 2025 Outlook*
Net Sales Down 2.5% - 2.8%
Adjusted EBITDA $395 million to $397 million
Net interest expense ~$125 million
Capital Expenditures $125 million - $130 million
Depreciation & Amortization ~$200 million
Net Store Closures ~20

Fourth Quarter 2025 Outlook



 
Q4 2025 Outlook*
Net Sales Down low single digits year over year
Adjusted EBITDA $93 million to $95 million

*Assumptions in the outlook include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent, and that current or planned tariffs on imports into the U.S. from other countries remain at November 25, 2025 levels. Adjusted EBITDA is a non-GAAP financial measure and has not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the Securities and Exchange Commission.

(1) Adjusted EBITDA is a non-GAAP financial measure. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。